EWA
MYOK

Evolution Wealth Advisors’s MyoKardia, Inc. Common Stock MYOK Stock Holding History

Evolution Wealth Advisors’s Portfolio MYOK Stock Details MYOK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-175
Closed -$8K – 579
2020
Q1 		$8K Buy
+175
New +$11.2K ﹤0.01% 224

Other funds holding MYOK

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.75B AUM 68.58% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return

Evolution Wealth Advisors's MYOK Position: Q2 2020 in Review

Evolution Wealth Advisors sold out of MyoKardia, Inc. Common Stock (MYOK) in Q2 2020, closing a stake of 175 shares — an estimated $8K sold.

Evolution Wealth Advisors first reported a position in MYOK in Q1 2020 and held it in 1 quarter. The position peaked at $8K in Q1 2020. 235 funds tracked by Wall St. Rank hold MYOK as of Q2 2020.

  • Evolution Wealth Advisors reported no remaining MyoKardia, Inc. Common Stock position as of Q2 2020 after selling out during the quarter.
  • Evolution Wealth Advisors sold 175 MyoKardia, Inc. Common Stock shares in Q2 2020, an estimated $8K.
  • Evolution Wealth Advisors first reported a position in MyoKardia, Inc. Common Stock in Q1 2020 and held it in 1 quarter.
  • Evolution Wealth Advisors's MyoKardia, Inc. Common Stock position peaked at $8K in Q1 2020.
  • 235 funds tracked by Wall St. Rank held MyoKardia, Inc. Common Stock as of Q2 2020.

Based on Evolution Wealth Advisors's 13F filing for Q2 2020, filed 27 Jul 2020.